Syringes and Needles - Medical Devices Pipeline Assessment, 2019

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Syringes and Needles Overview

3 Products under Development

• 3.1 Syringes and Needles - Pipeline Products by Stage of Development
• 3.2 Syringes and Needles - Pipeline Products by Segment
• 3.3 Syringes and Needles - Pipeline Products by Territory
• 3.4 Syringes and Needles - Pipeline Products by Regulatory Path
• 3.5 Syringes and Needles - Pipeline Products by Estimated Approval Date

4 Syringes and Needles - Pipeline Products under Development by Companies

• 4.1 Syringes and Needles Companies - Pipeline Products by Stage of Development
• 4.2 Syringes and Needles - Pipeline Products by Stage of Development

5 Syringes and Needles Companies and Product Overview

• 5.1 Aquabiliti Company Overview
• 5.2 ARTE CORPORATION Company Overview
• 5.3 Baxter International Inc Company Overview
• 5.4 Becton Dickinson and Co Company Overview
• 5.5 Cincinnati Children's Hospital Medical Center Company Overview
• 5.6 Cook Regentec LLC Company Overview
• 5.7 Daxor Corp Company Overview
• 5.8 Galderma SA Company Overview
• 5.9 Globe Medical Tech Inc (Inactive) Company Overview
• 5.10 Injeq Oy Company Overview
• 5.11 iScience Interventional Inc Company Overview
• 5.12 Johns Hopkins University Company Overview
• 5.13 Medigard Ltd Company Overview
• 5.14 MonuMedical LLC Company Overview
• 5.15 Neuroelectrics Company Overview
• 5.16 NuvOx Pharma LLC Company Overview
• 5.17 Olberon Medical Innovation SAS Company Overview
• 5.18 Protectus Medical Devices, Inc. Company Overview
• 5.19 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
• 5.20 Rutgers The State University of New Jersey Company Overview
• 5.21 Silmag SA Company Overview
• 5.22 Syrindicare, Inc Company Overview
• 5.23 Telezon Ltd Company Overview
• 5.24 Unilife Corporation Company Overview
• 5.25 University of California Berkeley Company Overview
• 5.26 University of California Irvine Company Overview
• 5.27 University of Louisville Company Overview
• 5.28 University of Massachusetts Amherst Company Overview
• 5.29 University of South Florida Company Overview
• 5.30 Virginia Commonwealth University Company Overview

6 Syringes and Needles- Recent Developments

• 6.1 Jul 13, 2018: Vitrolife: Interim report January - June 2018
• 6.2 Jul 12, 2018: Personnel Changes in Supervisory and Management Board of Aesculap
• 6.3 Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation
• 6.4 Jul 08, 2018: Vetter Strikes out on New Pathways to Further Develop the Injection Process
• 6.5 Jun 27, 2018: BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative to Improve Patient Outcomes
• 6.6 Jun 27, 2018: Finnish Lojer to acquire the Nordics’ largest supplier of acupuncture needles
• 6.7 Jun 26, 2018: InfuSystem Holdings Selected as an Official Distributor of CADD Infusion Therapy Products by Smiths Medical
• 6.8 Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection
• 6.9 Jun 21, 2018: Clinical Innovations to Host Forum, Demonstrate Products at Association of Women’s Health, Obstetric and Neonatal Nurses Convention
• 6.10 Jun 21, 2018: West Pharmaceutical Services names Bernard Birkett As Chief Financial Officer
• 6.11 Jun 19, 2018: Cardinal Health Foundation Awards Over $3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia
• 6.12 Jun 12, 2018: Daxor Names Kathryn A. Kornafel As Vice President Of Marketing And Commercial Development
• 6.13 Jun 08, 2018: B. Braun to Showcase Its Commitment to Reducing Healthcare-Associated Infections with Products and Education at APIC 2018
• 6.14 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
• 6.15 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us